inverse
limited
all
code
partial
bolus
maximum
tamoxifen
1,5
month
four
rapid
surgical
concept
overlap
trastuzumab
discordant
infiltrant
amplification
depend
radical
iii
technique
overlying
passage
recurrence
0
charge
nominal
84
fréquent
late
suite
cm2
controlatérale
al.
division
family
hormone
risk
advantage
resection
very
activation
infraclinique
mg
fat
choice
sensation
electron
nodule
we
peripheral
placebo
affect
examen
difference
exact
condition
essai
implant
progression
level
transmission
cause
toxicité
list
solution
phosphorylation
t1
large
cas
systemic
especially
minimal
48
small
biological
round
mm
programme
glucose
population
199
core
antigen
node
skin
chimiothérapie
direct
tumoral
second
design
tangential
insertion
infiltration
further
analogue
depression
even
index
117
hormonal
appear
calcium
section
disease
4
thickness
cell
public
axial
version
suspect
phosphatase
reconstruction
new
net
neu
boost
method
coefficient
overexpressed
cathepsin
pose
confirmation
échographie
residual
évolution
understanding
localisation
écart-type
protection
same
alone
ratio
100
diagnostic
table
107
change
105
great
substance
survivor
33
32
study
30
37
36
35
34
permis
trial
amount
reduction
bon
social
action
inhibiteur
gene
der
reste
240
deuxième
assistance
term
projection
classification
marginal
cosmetic
utilisation
visible
decrease
fluorescent
marker
concomitant
total
faveur
select
red
présence
perfusion
clinique
vascular
distinct
polype
hospital
42
direction
only
induction
sequence
85%
sample
pathologie
examination
therefore
automate
m2
interruption
comparant
panel
type
1000
sort
radiothérapie
mois
pratique
trait
acceptable
apparent
limitation
improve
it
99
glass
repopulation
train
surgeon
excellent
91
90
93
92
95
94
97
96
1991
1990
1993
1992
1995
1994
1997
1996
1999
1998
challenge
work
iridium
minimum
101
taux
male
mo
history
control
heart
figure
do
similaire
0.5
0.4
agent
risque
high
way
inflammation
concordant
scar
yet
générale
transduction
information
monitoring
syndrome
flap
provide
discussion
complication
feature
rapport
systématique
prognosis
antiaromatase
vital
commercial
animal
histologique
interview
nombre
souvent
translocation
146
147
alternative
cytokine
description
prognostic
modulation
sacrifice
agarose
spot
estrone
148
brachytherapy
date
such
horizontal
prostate
response
maligne
status
diffusion
stress
no
randomised
80
joint
quadrant
cascade
si
tumeur
gamma
long
correlation
sentinelle
mastectomy
se
mieux
restriction
oncology
letrozole
help
food
radiation
oblique
major
moyen
characteristic
comme
report
attitude
évidence
anthracycline
135
dye
existence
still
compatible
before
24
25
26
27
group
ligand
mais
23
personal
lateral
presence
28
29
manière
caractère
absence
production
suspicion
minute
oncologist
inhibitor
histological
2+
maximal
then
them
good
adjacent
combination
fragment
cyclophosphamide
vitro
également
multifocale
exon
hormonothérapie
they
optimal
not
1b
rotation
association
mammographique
supérieure
stopper
mental
coping
phenotype
23,7
composition
micro
mode
involvement
choix
difficult
side
vessel
mean
few
synchrone
domain
square
significantly
secondary
tension
there
fish
donnée
échographique
product
applicable
costal
society
68
fraction
favorable
measurement
82
et
mapping
81
sexual
array
paclitaxel
exemestane
rt
shown
140
item
108
statut
crucial
microscope
research
increase
adverse
investigation
health
rare
7
internet
coordination
issue
correct
assurance
common
1986
perception
linear
creux
controlatéral
postoperative
gène
million
caspase
isotope
standard
position
reason
base
que
oligonucleotide
peptide
van
kit
wall
1983
interaction
précoce
angle
route
21
accumulation
length
place
100000
discordance
signature
promotion
marqueur
scarf
first
résultat
prospective
preoperative
already
entourage
grade
distal
mise
number
rank
one
donc
1988
directly
invasion
600
impossible
175
quality
mammary
size
min
majorité
management
publication
service
intention
introduction
gauche
system
least
plastic
stimulation
their
180
responsable
185
chemotherapy
molecular
isodose
final
low
similitude
ainsi
relationship
that
thorax
thoracic
lower
60
transverse
basal
part
tissu
estrogen
trois
102
institution
symptom
p53
epidermal
distance
13
12
15
target
17
culture
19
18
aspiration
progestérone
rate
bed
project
composante
reproduction
103
outcome
comparaison
acquisition
perspective
fréquence
tumorectomie
clip
adolescent
cinq
correction
premier
expertise
argument
lin
case
rat
analysis
have
need
concentration
border
option
conversion
jour
57
quartile
pleural
efficacité
alors
able
mechanism
arm
note
also
internal
pivotal
fonction
deux
so
modifier
impairment
suivi
blue
needle
multiple
allow
64
normal
collaboration
incidence
luminal
centrifugation
carcinome
76
75
1
carcinoma
plan
71
organization
phase
alpha
segment
79
dorsal
planning
muscle
kg
observation
épidémiologique
failure
mobile
probablement
significatif
drive
face
postmenopausal
which
contrôle
suture
anticancer
récemment
notion
respect
prolifération
d.
superior
particularly
gold
show
parental
probe
seule
soluble
mammaire
relation
conclusion
abdomen
dimension
fine
principal
impact
latent
knowledge
implementation
mastectomie
proportion
kinase
short
terminal
enzyme
actin
factor
8
adequate
bisphosphonate
local
inferior
11
his
dominant
above
di
routine
overall
cosmesis
métastase
collection
120
beam
125
familial
128
2
14
gray
evolution
incision
organ
récidive
16
median
vincristine
medial
mammography
partir
radiotherapy
130
source
contain
première
implication
view
fait
irradiation
set
aspect
observer
our
sensitivity
cellulaire
comparable
sex
detection
conservateur
see
individual
college
migration
surgery
contour
breast
page
notamment
prévention
wire
potential
parent
expert
dépistage
pattern
effet
canalaire
importance
3
score
identification
membrane
probably
approach
available
accord
recently
43
vertical
nature
targeted
confusion
lymphocyte
attention
however
incident
cerb-2
métachrone
interface
article
115
cervical
problem
linkage
exclusion
unilatéral
reaction
recherche
prescription
22
aromatase
avoid
many
region
terme
drug
endométrial
susceptible
patiente
tout
encore
5,3
long-term
distinction
contribution
estimation
expression
organisation
comment
2003
côté
cm
point
simple
invasive
period
satisfaction
diminution
62
63
non
adaptation
66
seuil
sentinel
1985
250
seulement
scanner
multifocal
bilatéral
intracanalaire
invasif
abdominal
capable
addition
après
extraction
incubation
permanent
initiation
104
clinical
même
meeting
500
ganglion
field
life
rather
corresponding
retrospective
83
pulmonaire
aussi
thousand
400
photon
39
ductal
2,3
cranial
168
external
geste
fortement
160
former
20
exception
main
laser
symptôme
38
curage
taxane
cluster
technical
randomisation
1980
ml
externe
situation
balance
margin
guide
lobulaire
force
receptor
orientation
axillaire
ne
gel
site
surface
ii
soit
atypique
experience
simulator
partner
protein
technology
conserve
particulier
result
3+
pas
participant
primary
make
administration
témoin
surveillance
microarray
complex
film
colorectal
modification
consultation
several
survival
simulation
development
ni
fibrose
groupe
effect
hand
usually
moment
user
student
opinion
palpable
calcification
six
focal
destruction
133
concordance
drain
center
whole
depending
well
faible
80%
double
severe
contact
47
therapy
facteur
800
self
subgroup
45
taille
dose
stroma
métastatique
body
distant
human
différence
respectivement
ng
univariate
insulin-like
femme
traitement
cut
cancer
candidate
application
absorption
longitudinal
indispensable
seem
improvement
instrument
difficile
ganglionnaire
treatment
31
stade
transformation
saturation
evaluation
fracture
couple
cf.
possible
regard
early
fusion
inhibition
five
performance
59
unique
stable
log-rank
période
desire
loss
axillary
pertinent
58
référence
61
55
54
sous-groupe
56
51
50
53
52
consensus
nipple
drainage
become
dilution
lymphocytaire
disorder
signal
degré
3000
accessible
poor
right
old
définir
200
67
global
pregnancy
tumor
growth
110
69
questionnaire
5
119
118
transport
chirurgical
specific
2,6
dense
for
peu
tube
centre
pronostic
when
86
critical
mutation
estradiol
indication
participation
stéroïdien
be
patient
energy
moins
300
thérapeutique
journal
dissection
tumour
expansion
antécédent
bp
vivo
menopause
substitution
très
fibrosis
post
30%
stage
littérature
77
craniocaudal
central
être
extension
based
tracer
origine
cadre
74
act
73
ou
therapeutic
sept
block
72
two
65
88
inclusion
implantation
communication
image
70
stratification
série
three
lung
female
effort
mammographie
survie
intervention
remain
1987
1984
radiology
21.1
log
her
area
psychosocial
support
initial
question
genetic
sternal
1989
transcription
strict
conservation
structure
lot
lésion
78
formation
87
tyrosine
function
9
complete
offer
112
reduce
6
analyse
volume
ailleurs
posterior
construction
gain
cycle
lymph
pg
injection
mm2
with
he
excision
absent
étude
fluorescence
circulation
represent
up
us
below
89
exploration
monoclonal
emotional
distribution
clone
similar
sein
traduction
150
152
constant
154
anastrozole
certain
abstract
year
influence
al
deep
an
revanche
quantification
single
cure
hypertension
epithelial
follow-up
radio-induite
indirect
chromosome
physical
pmol
variance
caspase-3
nm
national
49
46
personnel
44
seul
generally
2000
40
41
end
adjuvant
motif
other
role
endométriale
spatial
test
2006
prise
85
10
28,6
2004
collaborative
2005
variation
disease-free
chance
important
stromal
infection
suppression
tamoxifène
variable
pool
macrophage
fluence
lead
gynécologique
98
niveau
age
interval
mitoxantrone
original
2002
gradient
depth
2001
mass
2007
diagnosis
time
international
validation
oral
decision
diagnostique
